Dietary n-3 Polyunsaturated Fatty Acids (PUFA) Decrease Obesity-Associated Th17 Cell-Mediated Inflammation during Colitis

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Monk, Jennifer M ^a   Hou, Tim Y ^a   Turk, Harmony F ^a   Weeks, Brad ^b   Wu, Chaodong ^a   McMurray, David N ^a,c   Chapkin, Robert S ^a,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; RESISTIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; COLITIS; COLON; CONTROLLED STUDY; DISEASE SEVERITY; EX VIVO STUDY; GENE EXPRESSION; GENE REPRESSION; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; INTRAABDOMINAL FAT; LIPID DIET; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; SPLEEN; TH1 CELL; TH17 CELL;

ADIPOSE TISSUE; ANIMALS; COLITIS; COLON; CYTOKINES; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; GENE EXPRESSION PROFILING; INFLAMMATION; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MICE; OBESITY; PHENOTYPE; TH1 CELLS; TH17 CELLS;

MUS;

EID: 84869214172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049739     Document Type: Article

References (65)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL, (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307: 491-497.
2. Kahn SE, Hull RL, Utzschneider KM, (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846.
3. Kalupahana NS, Moustaid-Moussa N, Claycombe KJ, (2012) Immunity as a link between obesity and insulin resistance. Mol Aspects Med 33: 26-34.
4. Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, et al. (2005) Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 48: 2365-2375.
5. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, et al. (2006) Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49: 394-397.
6. Flachs P, Ruhl R, Hensler M, Janovska P, Zouhar P, et al. (2011) Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. Diabetologia 54: 2626-2638.
7. Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, et al. (2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23: 1946-1957.
8. Hsueh HW, Zhou Z, Whelan J, Allen KG, Moustaid-Moussa N, et al. (2011) Stearidonic and eicosapentaenoic acids inhibit interleukin-6 expression in ob/ob mouse adipose stem cells via Toll-like receptor-2-mediated pathways. J Nutr 141: 1260-1266.
9. Mori T, Kondo H, Hase T, Tokimitsu I, Murase T, (2007) Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57BL/6J mice. J Nutr 137: 2629-2634.
10. Ruzickova J, Rossmeisl M, Prazak T, Flachs P, Sponarova J, et al. (2004) Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 39: 1177-1185.
11. Takahashi Y, Ide T, (2000) Dietary n-3 fatty acids affect mRNA level of brown adipose tissue uncoupling protein 1, and white adipose tissue leptin and glucose transporter 4 in the rat. Br J Nutr 84: 175-184.
12. Todoric J, Loffler M, Huber J, Bilban M, Reimers M, et al. (2006) Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 49: 2109-2119.
13. Kong SC, Hurlstone DP, Pocock CY, Walkington LA, Farquharson NR, et al. (2005) The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol 39: 138-141.
14. Turner D, Shah PS, Steinhart AH, Zlotkin S, Griffiths AM (2010) Maintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): A systematic review and meta-analyses. Inflamm Bowel Dis.
15. Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S, (2010) Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol 30: 80-89.
16. Holtta V, Klemetti P, Sipponen T, Westerholm-Ormio M, Kociubinski G, et al. (2008) IL-23/IL-17 immunity as a hallmark of Crohn's disease. Inflamm Bowel Dis 14: 1175-1184.
17. Liu ZJ, Yadav PK, Su JL, Wang JS, Fei K, (2009) Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 15: 5784-5788.
18. Sarra M, Pallone F, Macdonald TT, Monteleone G, (2010) IL-23/IL-17 axis in IBD. Inflamm Bowel Dis 16: 1808-1813.
19. Shih DQ, Targan SR, (2008) Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol 14: 390-400.
20. Zenewicz LA, Antov A, Flavell RA, (2009) CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med 15: 199-207.
21. Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, et al. (2007) Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132: 2359-2370.
22. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, et al. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116: 1310-1316.
23. Zhang P, Kim W, Zhou L, Wang N, Ly LH, et al. (2006) Dietary fish oil inhibits antigen-specific murine Th1 cell development by suppression of clonal expansion. J Nutr 136: 2391-2398.
24. Zhang P, Smith R, Chapkin RS, McMurray DN, (2005) Dietary (n-3) polyunsaturated fatty acids modulate murine Th1/Th2 balance toward the Th2 pole by suppression of Th1 development. J Nutr 135: 1745-1751.
25. Monk JM, Jia Q, Callaway E, Weeks B, Alaniz RC, et al. (2012) Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in Fat-1 mice. J Nutr 142: 117-124.
26. Bertin B, Desreumaux P, Dubuquoy L, (2010) Obesity, visceral fat and Crohn's disease. Curr Opin Clin Nutr Metab Care 13: 574-580.
27. John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA, (2006) Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther 23: 1511-1523.
28. Peyrin-Biroulet L, Chamaillard M, Gonzalez F, Beclin E, Decourcelle C, et al. (2007) Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut 56: 577-583.
29. Sheehan AL, Warren BF, Gear MW, Shepherd NA, (1992) Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg 79: 955-958.
30. Smedh K, Olaison G, Nystrom PO, Sjodahl R, (1993) Intraoperative enteroscopy in Crohn's disease. Br J Surg 80: 897-900.
31. Desreumaux P, Ernst O, Geboes K, Gambiez L, Berrebi D, et al. (1999) Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 117: 73-81.
32. Batra A, Zeitz M, Siegmund B, (2009) Adipokine signaling in inflammatory bowel disease. Inflamm Bowel Dis 15: 1897-1905.
33. Paul G, Schaffler A, Neumeier M, Furst A, Bataillle F, et al. (2006) Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 12: 471-477.
34. Hass DJ, Brensinger CM, Lewis JD, Lichtenstein GR, (2006) The impact of increased body mass index on the clinical course of Crohn's disease. Clin Gastroenterol Hepatol 4: 482-488.
35. Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre JP, et al. (2002) Crohn's disease clinical course and severity in obese patients. Clin Nutr 21: 51-57.
36. Winer S, Paltser G, Chan Y, Tsui H, Engleman E, et al. (2009) Obesity predisposes to Th17 bias. Eur J Immunol 39: 2629-2635.
37. Kanneganti TD, Dixit VD, (2012) Immunological complications of obesity. Nat Immunol 13: 707-712.
38. Kim W, McMurray DN, Chapkin RS, (2010) n-3 polyunsaturated fatty acids-physiological relevance of dose. Prostaglandins Leukot Essent Fatty Acids 82: 155-158.
39. Depner CM, Torres-Gonzalez M, Tripathy S, Milne G, Jump DB, (2012) Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese ldlr-/- mice. J Nutr 142: 1495-1503.
40. Huo Y, Guo X, Li H, Wang H, Zhang W, et al. (2010) Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates systemic insulin resistance and adipose tissue inflammatory response. J Biol Chem 285: 3713-3721.
41. Wirtz S, Neufert C, Weigmann B, Neurath MF, (2007) Chemically induced mouse models of intestinal inflammation. Nat Protoc 2: 541-546.
42. Jia Q, Lupton JR, Smith R, Weeks BR, Callaway E, et al. (2008) Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res 68: 3985-3991.
43. Stienstra R, Duval C, Keshtkar S, van der Laak J, Kersten S, et al. (2008) Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue. J Biol Chem 283: 22620-22627.
44. Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, et al. (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58: 2574-2582.
45. Lumeng CN, Bodzin JL, Saltiel AR, (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117: 175-184.
46. Fan YY, Monk JM, Hou TY, Callway E, Vincent L, et al. (2012) Characterization of an arachidonic acid-deficient (Fads1 knockout) mouse model. J Lipid Res 53: 1287-1295.
47. Hou TY, Monk JM, Fan YY, Barhoumi R, Chen YQ, et al. (2012) n-3 polyunsaturated fatty acids suppress phosphatidylinositol 4,5-bisphosphate-dependent actin remodelling during CD4+ T-cell activation. Biochem J 443: 27-37.
48. Waldner MJ, Neurath MF (2009) Chemically induced mouse models of colitis. Curr Protoc Pharmacol Chapter 5: Unit 5 55.
49. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, et al. (2003) Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 88: 5452-5455.
50. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, et al. (2007) Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 293: E656-665.
51. Claria J, Gonzalez-Periz A, Lopez-Vicario C, Rius B, Titos E, (2011) New insights into the role of macrophages in adipose tissue inflammation and Fatty liver disease: modulation by endogenous omega-3 Fatty Acid-derived lipid mediators. Front Immunol 2: 49.
52. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR, (2007) Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56: 16-23.
53. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
54. Riordan NH, Ichim TE, Min WP, Wang H, Solano F, et al. (2009) Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 7: 29.
55. Ivanov II, Zhou L, Littman DR, (2007) Transcriptional regulation of Th17 cell differentiation. Semin Immunol 19: 409-417.
56. Abraham C, Cho JH, (2009) IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med 60: 97-110.
57. Abraham C, Cho J, (2009) Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 15: 1090-1100.
58. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, et al. (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50: 2199-2202.
59. Kalupahana NS, Claycombe KJ, Moustaid-Moussa N, (2011) (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. Adv Nutr 2: 304-316.
60. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
61. Gordon S, Taylor PR, (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
62. Nieto N, Torres MI, Rios A, Gil A, (2002) Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr 132: 11-19.
63. Kelsall BL, (2008) Innate and adaptive mechanisms to control [corrected] pathological intestinal inflammation. J Pathol 214: 242-259.
64. Gu Y, Yang J, Ouyang X, Liu W, Li H, et al. (2008) Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 38: 1807-1813.
65. Huber S, Gagliani N, Esplugues E, O'Connor W Jr, Huber FJ, et al. (2011) Th17 cells express interleukin-10 receptor and are controlled by Foxp3 and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34: 554-565.